Go Pro

IceCure Medical (ICCM) Competitors

IceCure Medical logo
$2.89 0.00 (0.00%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$3.02 +0.14 (+4.67%)
As of 07/31/2026 07:02 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ICCM vs. BDMD, IINN, QTI, QTEX, and STRR

Should you buy IceCure Medical stock or one of its competitors? MarketBeat compares IceCure Medical with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with IceCure Medical include Baird Medical Investment (BDMD), Inspira Technologies OXY B.H.N. (IINN), QT Imaging (QTI), Inspira Technologies OXY B.H.N. (QTEX), and Star Equity (STRR).

How does IceCure Medical compare to Baird Medical Investment?

Baird Medical Investment (NASDAQ:BDMD) and IceCure Medical (NASDAQ:ICCM) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, media sentiment, dividends, earnings and valuation.

In the previous week, IceCure Medical had 2 more articles in the media than Baird Medical Investment. MarketBeat recorded 2 mentions for IceCure Medical and 0 mentions for Baird Medical Investment. Baird Medical Investment's average media sentiment score of 1.43 beat IceCure Medical's score of 0.72 indicating that Baird Medical Investment is being referred to more favorably in the media.

Company Overall Sentiment
Baird Medical Investment Positive
IceCure Medical Positive

Baird Medical Investment has a beta of -1.17, meaning that its share price is 217% less volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.43, meaning that its share price is 57% less volatile than the broader market.

Baird Medical Investment has a net margin of 0.00% compared to IceCure Medical's net margin of -441.60%. Baird Medical Investment's return on equity of 0.00% beat IceCure Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Baird Medical InvestmentN/A N/A N/A
IceCure Medical -441.60%-211.73%-119.13%

Baird Medical Investment has higher revenue and earnings than IceCure Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Baird Medical Investment$22.54M1.87N/AN/AN/A
IceCure Medical$3.38M2.93-$15.06M-$7.21N/A

19.8% of Baird Medical Investment shares are owned by institutional investors. Comparatively, 0.6% of IceCure Medical shares are owned by institutional investors. 78.9% of Baird Medical Investment shares are owned by insiders. Comparatively, 2.4% of IceCure Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

IceCure Medical has a consensus price target of $62.70, indicating a potential upside of 2,069.55%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts clearly believe IceCure Medical is more favorable than Baird Medical Investment.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Baird Medical Investment
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
IceCure Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

Summary

Baird Medical Investment beats IceCure Medical on 7 of the 13 factors compared between the two stocks.

How does IceCure Medical compare to Inspira Technologies OXY B.H.N.?

IceCure Medical (NASDAQ:ICCM) and Inspira Technologies OXY B.H.N. (NASDAQ:IINN) are both small-cap healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, analyst recommendations, earnings, media sentiment, institutional ownership, valuation, profitability and risk.

IceCure Medical has a beta of 0.43, meaning that its share price is 57% less volatile than the broader market. Comparatively, Inspira Technologies OXY B.H.N. has a beta of 2.16, meaning that its share price is 116% more volatile than the broader market.

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than IceCure Medical. MarketBeat recorded 3 mentions for Inspira Technologies OXY B.H.N. and 2 mentions for IceCure Medical. IceCure Medical's average media sentiment score of 0.72 beat Inspira Technologies OXY B.H.N.'s score of 0.00 indicating that IceCure Medical is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IceCure Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. 2.4% of IceCure Medical shares are held by insiders. Comparatively, 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

IceCure Medical presently has a consensus price target of $62.70, suggesting a potential upside of 2,069.55%. Given IceCure Medical's stronger consensus rating and higher possible upside, equities research analysts clearly believe IceCure Medical is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

Inspira Technologies OXY B.H.N. has lower revenue, but higher earnings than IceCure Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IceCure Medical$3.38M2.93-$15.06M-$7.21N/A
Inspira Technologies OXY B.H.N.$289K111.95-$13.22MN/AN/A

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to IceCure Medical's net margin of -441.60%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat IceCure Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
IceCure Medical-441.60% -211.73% -119.13%
Inspira Technologies OXY B.H.N. N/A N/A N/A

Summary

Inspira Technologies OXY B.H.N. beats IceCure Medical on 9 of the 14 factors compared between the two stocks.

How does IceCure Medical compare to QT Imaging?

IceCure Medical (NASDAQ:ICCM) and QT Imaging (NASDAQ:QTI) are both small-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their valuation, profitability, earnings, dividends, institutional ownership, media sentiment, analyst recommendations and risk.

IceCure Medical presently has a consensus price target of $62.70, suggesting a potential upside of 2,069.55%. Given IceCure Medical's stronger consensus rating and higher possible upside, analysts plainly believe IceCure Medical is more favorable than QT Imaging.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
QT Imaging
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

IceCure Medical has a beta of 0.43, meaning that its share price is 57% less volatile than the broader market. Comparatively, QT Imaging has a beta of -0.04, meaning that its share price is 104% less volatile than the broader market.

QT Imaging has a net margin of -58.93% compared to IceCure Medical's net margin of -441.60%. IceCure Medical's return on equity of -211.73% beat QT Imaging's return on equity.

Company Net Margins Return on Equity Return on Assets
IceCure Medical-441.60% -211.73% -119.13%
QT Imaging -58.93%-4,220.38%-51.77%

In the previous week, QT Imaging had 1 more articles in the media than IceCure Medical. MarketBeat recorded 3 mentions for QT Imaging and 2 mentions for IceCure Medical. QT Imaging's average media sentiment score of 1.34 beat IceCure Medical's score of 0.72 indicating that QT Imaging is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
IceCure Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
QT Imaging
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

0.6% of IceCure Medical shares are owned by institutional investors. Comparatively, 24.2% of QT Imaging shares are owned by institutional investors. 2.4% of IceCure Medical shares are owned by insiders. Comparatively, 25.4% of QT Imaging shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

IceCure Medical has higher earnings, but lower revenue than QT Imaging. QT Imaging is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IceCure Medical$3.38M2.93-$15.06M-$7.21N/A
QT Imaging$18.92M1.96-$21.08M-$1.24N/A

Summary

IceCure Medical and QT Imaging tied by winning 8 of the 16 factors compared between the two stocks.

How does IceCure Medical compare to Inspira Technologies OXY B.H.N.?

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and IceCure Medical (NASDAQ:ICCM) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, earnings, institutional ownership, dividends, valuation, media sentiment, analyst recommendations and risk.

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 0.6% of IceCure Medical shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Comparatively, 2.4% of IceCure Medical shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Inspira Technologies OXY B.H.N. has a beta of 4.2, meaning that its stock price is 320% more volatile than the broader market. Comparatively, IceCure Medical has a beta of 0.43, meaning that its stock price is 57% less volatile than the broader market.

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to IceCure Medical's net margin of -441.60%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat IceCure Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
Inspira Technologies OXY B.H.N.N/A N/A N/A
IceCure Medical -441.60%-211.73%-119.13%

IceCure Medical has a consensus price target of $62.70, suggesting a potential upside of 2,069.55%. Given IceCure Medical's stronger consensus rating and higher probable upside, analysts plainly believe IceCure Medical is more favorable than Inspira Technologies OXY B.H.N..

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inspira Technologies OXY B.H.N.
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
IceCure Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40

In the previous week, Inspira Technologies OXY B.H.N. and Inspira Technologies OXY B.H.N. both had 2 articles in the media. IceCure Medical's average media sentiment score of 0.72 beat Inspira Technologies OXY B.H.N.'s score of 0.63 indicating that IceCure Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Inspira Technologies OXY B.H.N.
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
IceCure Medical
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than IceCure Medical.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inspira Technologies OXY B.H.N.$289K111.95-$13.22MN/AN/A
IceCure Medical$3.38M2.93-$15.06M-$7.21N/A

Summary

Inspira Technologies OXY B.H.N. beats IceCure Medical on 8 of the 13 factors compared between the two stocks.

How does IceCure Medical compare to Star Equity?

IceCure Medical (NASDAQ:ICCM) and Star Equity (NASDAQ:STRR) are related small-cap companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, valuation, media sentiment, analyst recommendations, institutional ownership, profitability and dividends.

Star Equity has higher revenue and earnings than IceCure Medical. Star Equity is trading at a lower price-to-earnings ratio than IceCure Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
IceCure Medical$3.38M2.93-$15.06M-$7.21N/A
Star Equity$172.16M0.23-$5.92M-$2.63N/A

0.6% of IceCure Medical shares are held by institutional investors. Comparatively, 3.8% of Star Equity shares are held by institutional investors. 2.4% of IceCure Medical shares are held by company insiders. Comparatively, 31.6% of Star Equity shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Star Equity has a net margin of -4.18% compared to IceCure Medical's net margin of -441.60%. Star Equity's return on equity of -4.04% beat IceCure Medical's return on equity.

Company Net Margins Return on Equity Return on Assets
IceCure Medical-441.60% -211.73% -119.13%
Star Equity -4.18%-4.04%-2.40%

IceCure Medical has a beta of 0.43, indicating that its share price is 57% less volatile than the broader market. Comparatively, Star Equity has a beta of 0.51, indicating that its share price is 49% less volatile than the broader market.

In the previous week, IceCure Medical had 2 more articles in the media than Star Equity. MarketBeat recorded 2 mentions for IceCure Medical and 0 mentions for Star Equity. Star Equity's average media sentiment score of 1.87 beat IceCure Medical's score of 0.72 indicating that Star Equity is being referred to more favorably in the news media.

Company Overall Sentiment
IceCure Medical Positive
Star Equity Very Positive

IceCure Medical presently has a consensus price target of $62.70, suggesting a potential upside of 2,069.55%. Star Equity has a consensus price target of $28.00, suggesting a potential upside of 161.32%. Given IceCure Medical's higher possible upside, analysts clearly believe IceCure Medical is more favorable than Star Equity.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
IceCure Medical
1 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.40
Star Equity
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.40

Summary

Star Equity beats IceCure Medical on 11 of the 16 factors compared between the two stocks.

Get IceCure Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for ICCM and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ICCM and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ICCM vs. The Competition

MetricIceCure MedicalHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$9.90M$5.68B$7.22B$12.31B
Dividend YieldN/A1.78%2.59%9.45%
P/E Ratio-0.4023.10282.6424.66
Price / Sales2.9357.02641.25110.26
Price / CashN/A32.2671.0259.62
Price / Book0.786.3111.095.90
Net Income-$15.06M$148.76M$3.50B$336.31M
7 Day Performance-6.17%1.77%-0.24%0.09%
1 Month Performance-45.27%5.34%-2.97%-5.67%
1 Year Performance-90.46%2.08%61.94%18.79%

IceCure Medical Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ICCM
IceCure Medical
3.3584 of 5 stars
$2.89
flat
$62.70
+2,069.6%
-90.6%$9.90M$3.38MN/A60
BDMD
Baird Medical Investment
1.4255 of 5 stars
$1.09
+0.9%
N/A-49.5%$44.67M$22.54MN/AN/A
IINN
Inspira Technologies OXY B.H.N.
0.0393 of 5 stars
$1.19
-6.3%
N/A-34.6%$42.78M$289KN/A20
QTI
QT Imaging
0.9915 of 5 stars
$3.09
-5.5%
N/A+39.4%$42.55M$18.92MN/AN/A
QTEX
Inspira Technologies OXY B.H.N.
0.4385 of 5 stars
$1.18
-0.8%
N/AN/A$42.42M$290KN/A20

Related Companies and Tools


This page (NASDAQ:ICCM) was last updated on 8/1/2026 by MarketBeat.com Staff.
From Our Partners